Federal grants to 7 Hills Pharma Inc
7 Hills Pharma Inc in Houston, Texas received $9.1 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Allergy and Infectious Diseases Research, with $5.2 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$9.1 million
- Awards6
- Awarded in FY 2025$0
- Largest award$3.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $2.2 million |
| FY 2022 | 1 | $999,300 |
| FY 2023 | 3 | $2.9 million |
| FY 2024 | 3 | $3.0 million |
| FY 2025 | 0 | $0 |
Programs that fund 7 Hills Pharma Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $5.2 million |
| Cancer Treatment Research | 2 | $3.0 million |
| Cardiovascular Diseases Research | 1 | $928,941 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 6 | $9.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Integrin activator-adjuvanted dna vaccine against trypanosoma cruzi infection - project summary/abstract trypanosoma cruzi (TC) is the causative agent of chagas disease (CD). With >7 million recorded cases, ~81 million at risk of tc exposure in latin america, and large-scale migration from endemic t | Allergy and Infectious Diseases Research | July 13, 2022 | $3.0 million |
| 7HP349, an integrin activator to treat patients with ANTI-PD-1 resistant solid tumors - project summary/abstract immuno-oncology (IO) therapies, particularly immune checkpoint inhibitors (ICIS) such as nivolumab (anti-pd- 1) and ipilimumab (ANTI-CTLA-4) have made rapid advances in inducing remarkabl | Cancer Treatment Research | September 19, 2023 | $2.0 million |
| 7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination - project summary/abstract americans aged =65 years accounted for 57% and 75% of all influenza-related hospitalizations and deaths, respectively, in the 2019-20 season, despite a vaccination rate of ~68 | Allergy and Infectious Diseases Research | April 25, 2023 | $1.9 million |
| Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors | Cancer Treatment Research | August 12, 2021 | $1.0 million |
| A small molecule integrin activator to enhance cord blood transplant | Cardiovascular Diseases Research | October 26, 2020 | $928,941 |
| Integrin activation to augment SARS-COV-2 vaccination - abstract on march 11, 2020 the world health organization (WHO) announced a global coronavirus disease 2019 (COVID-19) pandemic. The disease is characterized by severe flu-like symptoms, with advanced age (>65 years) an important risk factor for | Allergy and Infectious Diseases Research | April 30, 2021 | $297,724 |
Questions people ask
How much federal grant money does 7 Hills Pharma Inc get?
$9.1 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives 7 Hills Pharma Inc the most?
The Department of Health and Human Services, with $9.1 million in 6 awards.
What is 7 Hills Pharma Inc's largest federal grant?
$3.0 million under Allergy and Infectious Diseases Research, with its first action in the period on July 13, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund 7 Hills Pharma Inc?
Its largest are Allergy and Infectious Diseases Research, Cancer Treatment Research and Cardiovascular Diseases Research.
Other grant recipients in Houston
- Baylor College of Medicine
- The Univeristy of Texas M.D. Anderson Cancer Center
- Metropolitan Transit Authority of Harris County
- University of Texas Health Science Center at Houston
- Harris County
- University of Houston System
- William Marsh Rice University
- City of Houston
Largest federal grant recipients in Texas · Federal grants in Texas